Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
8.34
-0.14 (-1.65%)
At close: Nov 4, 2024, 4:00 PM
8.20
-0.14 (-1.68%)
After-hours: Nov 4, 2024, 7:33 PM EST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
$80,849
Profits / Employee
-$1,204,877
Market Cap
967.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Owens & Minor | 22,200 |
| MiMedx Group | 895 |
| Weave Communications | 844 |
| Relay Therapeutics | 323 |
| Arcutis Biotherapeutics | 296 |
| IGM Biosciences | 224 |
| 89bio | 70 |
| ArriVent BioPharma | 40 |
MESO News
- 5 days ago - Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024 - GlobeNewsWire
- 5 weeks ago - Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential - Seeking Alpha
- 5 weeks ago - Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch - GlobeNewsWire
- 2 months ago - Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024 - GlobeNewsWire
- 2 months ago - Mesoblast Financial Results and Corporate Update Webcast - GlobeNewsWire
- 3 months ago - Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2024 - GlobeNewsWire
- 3 months ago - FDA Accepts Mesoblast's Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) - GlobeNewsWire